Back

Prognostic value of serial SCAI staging in microaxial flow-pump-treated cardiogenic shock: impact of early hemodynamic trajectory on 30-day survival

30 August 2026 (11:05 - 11:15)
Organised by: Logo
Congress Presentation Part of: Cardiogenic shock in acute myocardial infarction: new phenotypes and prognostic markers Cardiogenic Shock ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Johannes Mierke

Dresden University Of Technology, Dresden (Germany)

5 More presentations in this session

Presentation thumbnail
Phenotype analysis reveals a “global collapse” cardiogenic shock signature despite VA-ECMO support in acute myocardial infarction – a subanalysis from ECLS-SHOCK
Doctor T. Thevathasan (Berlin, DE)
Abstract Slides
Presentation thumbnail
Association of pre-existing sodium-glucose cotransporter-2 inhibitor therapy with outcomes in patients presenting with cardiogenic shock: a retrospective cohort study
Doctor M. Kunz (Basel, CH)
Abstract Slides
Presentation thumbnail
Stroke-induced cardiac immune remodeling may influence cardiac outcomes in subsequent myocardial infarction
Doctor C. Liu (Shanghai, CN)
Abstract Slides
Presentation thumbnail
Hemodynamic profiles of STEMI patients at admission - prevalence and short-term outcomes of the novel PRESHOCK phenotype
Doctor S. Macherey-Meyer (Cologne, DE)
Abstract Slides
Presentation thumbnail
48-hour lactate-to-albumin ratio predicts 180-day mortality after microaxial flow pump support in cardiogenic shock
Doctor S. Kuroda (JP)
Abstract Slides

Access the full session

Session thumbnail
Cardiogenic shock in acute myocardial infarction: new phenotypes and prognostic markers
Video

The Event

Event poster

ESC Congress 2026

30 August 2026 11:05 CET
You may be interested in
thumbnail
Congress Presentation
Cardiogenic shock classification evaluation after cardiac surgery to predict in-hospital mortality
31 August 2025
thumbnail
Congress Session
How to manage mechanical circulatory support therapy in cardiogenic shock
24 March 2023
thumbnail
Congress Presentation
Real-world outcomes of microaxial flow pump use in cardiogenic shock: comparison with the DanGer Shock cohort
20 March 2026
thumbnail
Congress Presentation
Prognostic value of baseline lactate levels in patients with infarct-related cardiogenic shock with and without ECLS therapy- a substudy of the ECLS-SHOCK trial
21 March 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources